Skip to content

Clinical trials

Phase 3 Genetic Diseases, Inborn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 3 Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20071
20082
20096
20121
20133
20142
20163
20176
20187
20191
20201
20213
20225
20233
20243
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Active, not recruiting9
Recruiting7
Terminated3
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical7
Novo Nordisk A/S6
Regeneron Pharmaceuticals6
Vertex Pharmaceuticals Incorporated5
GenSight Biologics3
PTC Therapeutics3
FDA Office of Orphan Products Development2
Genzyme, a Sanofi Company2
Kastle Therapeutics, LLC2
Merz North America, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn65
Hematologic Diseases13
Musculoskeletal Diseases13
Nervous System Diseases13
Genetic Diseases, X-Linked11
Metabolic Diseases10
Metabolism, Inborn Errors9
Muscular Dystrophies8
Muscular Dystrophy, Duchenne8
Neuromuscular Diseases8

Trials

Showing 76 to 65 of 65. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.